GO:1905956 positive regulation of endothelial tube morphogenesis: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905956 describes any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis, a key step in building new blood and lymphatic vessels.
• Endothelial tube morphogenesis requires coordinated endothelial cell migration, proliferation, and lumen formation, and is positively regulated by growth factors, extracellular matrix cues, and intracellular signaling.
• Key positive regulators include VEGFR2 signaling, caveolin-1, CCN2, angiopoietin-2, thrombospondin-4, and extracellular vesicles from adipose stem cells [2,3,5,7,8,1].
• Dysregulation of endothelial tube morphogenesis contributes to tumor angiogenesis, vascular malformations such as moyamoya disease, and impaired lymphangiogenesis in Crohn's disease [3,6,1].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate regulators in endothelial tube formation assays [3,5,8].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to dissect positive regulators of endothelial tube morphogenesis.
Description
GO:1905956, positive regulation of endothelial tube morphogenesis, is a Gene Ontology biological process term that captures any signal or mechanism that enhances the formation of endothelial tubes, the fundamental structural units of blood and lymphatic vessels. Endothelial tube morphogenesis itself is a multi-step process in which endothelial cells migrate, align, and reorganize into hollow, lumen-containing tubes, a prerequisite for functional vascular networks during development, tissue repair, and tumor progression. Because this process is tightly controlled, its positive regulators are attractive targets for understanding angiogenesis and lymphangiogenesis in health and disease. Researchers study positive regulation of endothelial tube morphogenesis to identify molecular drivers of vessel formation and to test whether candidate genes causally enhance or impair tube formation [3,5]. For example, caveolin-1 is critical for endothelial tube formation and mural cell recruitment during tumor blood vessel maturation, while CCN2 promotes lymphangiogenesis through integrin αvβ5-ERK signaling. Extracellular vesicles from creeping fat stem cells can promote lymphatic function, highlighting intercellular communication as a positive regulatory layer. This article integrates the QuickGO definition with verified PubMed literature to outline the mechanisms, key genes, disease links, and experimental strategies for studying positive regulation of endothelial tube morphogenesis [4,2,3,5,7,8,1,6].
positive regulation of endothelial tube morphogenesis At A Glance
| GO ID | GO:1905956 |
|---|---|
| GO term | positive regulation of endothelial tube morphogenesis |
| Ontology | biological_process |
| Synonym | activation of endothelial tube morphogenesis; up regulation of endothelial tube morphogenesis; up-regulation of endothelial tube morphogenesis; upregulation of endothelial tube morphogenesis |
| Major function | Enhances the formation of endothelial tubes during angiogenesis and lymphangiogenesis |
| Related processes | Angiogenesis, vasculogenesis, lymphangiogenesis, vascular remodeling [4,6] |
| Key positive regulators | VEGFR2 signaling, caveolin-1, CCN2, angiopoietin-2, thrombospondin-4, extracellular vesicles [2,3,5,7,8,1] |
| Disease relevance | Cancer, moyamoya disease, Crohn's disease, vascular malformations [3,6,1] |
What Is GO:1905956?
Positive regulation of endothelial tube morphogenesis (GO:1905956) refers to any process that activates or increases the frequency, rate, or extent of endothelial tube morphogenesis, the biological process in which endothelial cells form tube-like structures that constitute blood and lymphatic vessels. This term covers positive regulatory inputs such as growth factor signaling, extracellular matrix interactions, and intracellular signaling cascades that enhance tube formation [4,2,3,5,7,8,1].
Why Is positive regulation of endothelial tube morphogenesis Important in Cell Biology?
Positive regulation of endothelial tube morphogenesis is central to understanding how new blood and lymphatic vessels are built, a process that underlies embryonic development, wound healing, and tumor progression. Identifying positive regulators provides mechanistic insight into angiogenesis and lymphangiogenesis and offers potential therapeutic targets for diseases characterized by excessive or insufficient vessel formation [4,3,5,1].
• Endothelial tube morphogenesis is a fundamental step in angiogenesis and vasculogenesis.
• Positive regulators determine the rate and extent of new vessel formation in development and repair.
• Tumor angiogenesis depends on positive regulation of endothelial tube morphogenesis.
• Lymphangiogenesis in Crohn's disease involves extracellular vesicle-mediated positive regulation.
• Moyamoya disease, a cerebrovascular disorder, is linked to vascular remodeling processes that include endothelial tube morphogenesis.
• Caveolin-1 positively regulates endothelial tube formation and mural cell recruitment in tumor vessels.
• CCN2 promotes lymphangiogenesis via integrin αvβ5-ERK signaling, a positive regulatory pathway.
• Angiopoietin-2 enhances osteogenic differentiation of bone marrow stem cells, indicating crosstalk with vascular signaling.
• Thrombospondin-4 drives lymphangiogenesis through cooperation with VEGF-C in bladder cancer.
• Aldosterone inhibits endothelial morphogenesis by downregulating VEGFR2, showing that negative regulation also informs positive pathways.
What Happens During positive regulation of endothelial tube morphogenesis?
Initiation by pro-angiogenic signals
In simple terms: Positive regulation starts when growth factors or other signals tell endothelial cells to form tubes.
Positive regulation of endothelial tube morphogenesis is initiated by pro-angiogenic cues such as VEGF-A binding to VEGFR2, which activates downstream signaling to promote endothelial cell migration, proliferation, and tube formation [4,2]. Aldosterone can inhibit this process by downregulating VEGFR2 expression, underscoring that VEGFR2 levels are a key control point for positive regulation. Extracellular vesicles from creeping fat stem cells can also deliver pro-lymphangiogenic signals that enhance lymphatic function.
Endothelial cell migration and alignment
In simple terms: Endothelial cells move and line up to form the walls of new tubes.
Once activated, endothelial cells migrate and align along extracellular matrix tracks, a step positively regulated by integrin signaling and matrix-bound factors [4,5]. CCN2 promotes lymphangiogenesis through integrin αvβ5-ERK signaling, demonstrating how matrix-integrin crosstalk positively regulates endothelial tube morphogenesis. Caveolin-1 is critical for endothelial tube formation and mural cell recruitment, linking membrane organization to positive regulation.
Lumen formation and tube stabilization
In simple terms: The cells hollow out to create a lumen and stabilize the new tube.
Lumen formation involves coordinated cell shape changes, junction remodeling, and apical-basal polarity, processes that are positively regulated by signaling pathways downstream of VEGFR2 and integrins [4,5]. Caveolin-1 supports both endothelial tube formation and mural cell recruitment, which stabilizes nascent vessels. Thrombospondin-4 cooperates with VEGF-C to drive lymphangiogenesis, contributing to tube stabilization in lymphatic vessels.
Crosstalk with mural and stem cells
In simple terms: Other cell types help the endothelial tubes mature and function.
Positive regulation of endothelial tube morphogenesis often involves crosstalk with mural cells, stem cells, and immune cells [3,7]. Angiopoietin-2 enhances osteogenic differentiation of bone marrow stem cells, indicating that vascular regulatory factors can influence stem cell behavior. Extracellular vesicles from creeping fat stem cells promote lymphatic function and restrain inflammation, showing that stem cell-derived signals positively regulate lymphatic tube morphogenesis.
Key Genes Involved in GO:1905956 positive regulation of endothelial tube morphogenesis
The following genes and proteins are experimentally implicated in positive regulation of endothelial tube morphogenesis or closely related angiogenic and lymphangiogenic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFR2 (KDR) | Receptor for VEGF-A; activates downstream pro-angiogenic signaling [2,4] | Target for modulating endothelial tube morphogenesis; downregulation by aldosterone inhibits morphogenesis |
| CAV1 | Caveolin-1; critical for endothelial tube formation and mural cell recruitment | Knockout studies show impaired tumor blood vessel maturation |
| CCN2 (CTGF) | Promotes lymphangiogenesis via integrin αvβ5-ERK pathway | Positive regulator of lymphatic tube morphogenesis; regulated by DUSP6 |
| ITGAV/ITGB5 | Integrin αvβ5; mediates CCN2-induced ERK signaling | Target for blocking lymphangiogenesis |
| DUSP6 | Dual-specificity phosphatase 6; regulates ERK signaling in lymphangiogenesis | Modulates CCN2-induced tube formation |
| ANGPT2 | Angiopoietin-2; enhances osteogenic differentiation of bone marrow stem cells | Links vascular signaling to stem cell differentiation |
| THBS4 | Thrombospondin-4; drives lymphangiogenesis with VEGF-C | Positive regulator in bladder cancer lymphangiogenesis |
| VEGFC | Vascular endothelial growth factor C; promotes lymphangiogenesis | Cooperates with THBS4 to enhance lymphatic tube formation |
| RNF213 | Ring finger protein 213; associated with moyamoya disease | Mutations linked to vascular remodeling; relevant to endothelial tube morphogenesis |
| PPARG | Peroxisome proliferator-activated receptor gamma; mediates aldosterone effects | Downregulates VEGFR2, inhibiting endothelial morphogenesis |
| NR3C2 (MR) | Mineralocorticoid receptor; mediates aldosterone signaling | Aldosterone inhibits endothelial morphogenesis via MR-PPARγ-VEGFR2 axis |
| CDH5 (VE-cadherin) | Endothelial adherens junction protein; essential for tube formation | Supports endothelial cell alignment and lumen formation |
| PECAM1 (CD31) | Endothelial cell adhesion molecule; involved in migration and tube formation | Marker and functional mediator of endothelial tube morphogenesis |
| FLT1 (VEGFR1) | Modulates VEGF signaling; can positively or negatively regulate angiogenesis | Fine-tunes VEGFR2-driven tube morphogenesis |
| NRP1 | Neuropilin-1; co-receptor for VEGF and semaphorins | Enhances VEGFR2 signaling in endothelial tube formation |
| TIE2 (TEK) | Angiopoietin receptor; regulates vessel stabilization and remodeling | Cooperates with ANGPT2 in vascular remodeling |
| PDGFB | Platelet-derived growth factor B; recruits mural cells | Supports mural cell recruitment during tube stabilization |
| HIF1A | Hypoxia-inducible factor 1-alpha; drives VEGF expression | Upstream positive regulator of endothelial tube morphogenesis under hypoxia |
How Is positive regulation of endothelial tube morphogenesis Regulated?
Positive regulation of endothelial tube morphogenesis is controlled by a balance of pro- and anti-angiogenic signals. VEGFR2 signaling is a central node; aldosterone downregulates VEGFR2 via PPARγ, thereby inhibiting endothelial morphogenesis. Caveolin-1 is required for tube formation and mural cell recruitment, and its loss impairs vessel maturation. CCN2-induced lymphangiogenesis is mediated by integrin αvβ5-ERK signaling and is regulated by DUSP6, which modulates ERK activity. Thrombospondin-4 cooperates with VEGF-C to drive lymphangiogenesis, providing another positive regulatory input. Extracellular vesicles from creeping fat stem cells promote lymphatic function, indicating that intercellular communication can positively regulate tube morphogenesis. Angiopoietin-2 enhances osteogenic differentiation of bone marrow stem cells, suggesting crosstalk between vascular and skeletal regulatory pathways.
positive regulation of endothelial tube morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAV1 | Tumor angiogenesis; impaired vessel maturation | CAV1 knockout endothelial cells; tube formation assay |
| THBS4 | Bladder cancer lymphangiogenesis | THBS4 overexpression in lymphatic endothelial cells; lymphangiogenesis assay |
| CCN2 | Lymphangiogenesis; fibrosis | CCN2 knockout or knockdown in lymphatic endothelial cells; ERK signaling readout |
| RNF213 | Moyamoya disease; vascular remodeling | RNF213 mutant or knockout endothelial cells; tube formation under hypoxia |
| VEGFR2 (KDR) | Angiogenesis; endocrine regulation | VEGFR2 promoter reporter; aldosterone/PPARγ modulation |
Cancer and tumor angiogenesis
Positive regulation of endothelial tube morphogenesis is a hallmark of tumor angiogenesis, where cancer cells secrete pro-angiogenic factors that stimulate endothelial tube formation to supply the growing tumor [4,3]. Caveolin-1 is critical for tumor blood vessel maturation, and its loss leads to impaired tube formation and mural cell recruitment. Thrombospondin-4 drives lymphangiogenesis in bladder cancer through cooperation with VEGF-C, promoting lymphatic metastasis. Targeting positive regulators of tube morphogenesis is therefore a strategy to inhibit tumor vascularization [3,8].
Crohn's disease and lymphangiogenesis
In Crohn's disease, impaired lymphatic function contributes to inflammation and fibrosis. Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation, indicating that positive regulation of lymphatic tube morphogenesis can be therapeutic. These vesicles enhance lymphatic endothelial tube formation, linking GO:1905956 to inflammatory bowel disease.
Moyamoya disease and vascular remodeling
Moyamoya disease is a cerebrovascular disorder characterized by progressive stenosis of intracranial arteries and compensatory collateral vessel formation. LncRNA-mRNA co-expression profiles relative to vascular remodeling in moyamoya patients without RNF213 mutation suggest that dysregulated endothelial tube morphogenesis contributes to disease pathology. Positive regulators of tube morphogenesis may influence collateral formation and disease progression.
Metabolic and endocrine influences
Aldosterone inhibits endothelial morphogenesis and angiogenesis by downregulating VEGFR2 via PPARγ, linking endocrine signals to positive regulation of tube morphogenesis. This pathway may contribute to vascular complications in conditions with elevated aldosterone, such as hypertension and heart failure. Understanding positive regulation in this context could inform therapies that preserve endothelial function.
From positive regulation of endothelial tube morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene impair endothelial tube morphogenesis? | CRISPR knockout in HUVECs or lymphatic endothelial cells followed by tube formation assay [3,5] |
| Does a specific point mutation alter positive regulation? | CRISPR point mutation knock-in in endothelial cells; compare tube formation to wild type |
| Does a candidate gene enhance tube morphogenesis when overexpressed? | CRISPR overexpression (e.g., CRISPRa) or lentiviral overexpression in endothelial cells |
| Does a tag affect protein localization during tube formation? | CRISPR knock-in of fluorescent or epitope tag; live imaging |
| Which genes are required for lymphangiogenesis? | CRISPR library screening in lymphatic endothelial cells under VEGF-C stimulation [5,8] |
| Does a disease-associated variant affect tube morphogenesis? | Patient-derived iPSC endothelial cells with isogenic CRISPR correction |
How to Study the positive regulation of endothelial tube morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Tube formation assay | Network formation, tube length, branching [3,5] | Testing positive regulators in vitro [3,5] |
| CRISPR knockout screen | Genes required for tube morphogenesis [5,8] | Unbiased discovery of positive regulators [5,8] |
| RNA-seq | Transcriptional changes during tube formation | Identifying downstream effectors and disease signatures |
| Phospho-ERK Western blot | ERK pathway activation | Validating CCN2-integrin αvβ5 signaling |
| Live-cell imaging | Dynamic tube formation and protein localization | Visualizing caveolin-1 and junction remodeling |
| Immunohistochemistry | Vessel density and mural cell recruitment [3,8] | Assessing tumor angiogenesis and lymphangiogenesis [3,8] |
| Extracellular vesicle uptake assay | Transfer of pro-lymphangiogenic signals | Studying stem cell-derived vesicle effects on lymphatic endothelium |
| VEGFR2 promoter reporter | Transcriptional regulation of VEGFR2 | Testing aldosterone/PPARγ modulation |
Tube formation assay
The endothelial tube formation assay on Matrigel or collagen is the gold-standard in vitro method to measure positive regulation of endothelial tube morphogenesis [3,5]. Endothelial cells are seeded on matrix and monitored for network formation; positive regulators increase tube length, branching, and loop number [3,5]. This assay can be combined with CRISPR knockout or overexpression to test causality [3,8].
CRISPR screening and functional genomics
Pooled CRISPR knockout or activation screens in endothelial cells under pro-angiogenic conditions can identify positive regulators of tube morphogenesis [5,8]. Hits are validated by individual gene knockout and tube formation assays. Library screening enables unbiased discovery of genes that enhance or are required for tube formation [5,8].
RNA sequencing and transcriptomics
RNA-seq of endothelial cells during tube morphogenesis reveals transcriptional programs driven by positive regulators. Co-expression analysis of lncRNAs and mRNAs in moyamoya disease has identified vascular remodeling signatures relevant to tube morphogenesis. Transcriptomic profiling can also uncover downstream effectors of VEGFR2, CCN2, and THBS4 signaling [2,5,8].
Protein signaling and imaging
Western blotting and phospho-antibody arrays measure ERK, AKT, and other signaling pathways activated during positive regulation [5,2]. Live-cell imaging of fluorescently tagged proteins (e.g., caveolin-1, VE-cadherin) visualizes tube formation dynamics. Immunohistochemistry of tumor or lymphatic tissues assesses vessel density and maturation [3,8].
How CRISPR Can Be Used to Study GO:1905956 positive regulation of endothelial tube morphogenesis
Knockout
CRISPR knockout of candidate positive regulators (e.g., CAV1, CCN2, THBS4) in endothelial cells followed by tube formation assays can determine whether the gene is required for endothelial tube morphogenesis [3,5,8]. For example, CAV1 knockout impairs tube formation and mural cell recruitment in tumor models. Knockout of CCN2 or its integrin partners reduces lymphangiogenesis.
Point Mutation
CRISPR point mutation knock-in can model disease-associated variants or phospho-null/phospho-mimetic mutations in regulators such as VEGFR2 or RNF213 [2,6]. These models test whether specific residues are required for positive regulation of tube morphogenesis [2,6]. Isogenic pairs control for background genetic variation.
Knock-in
CRISPR knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags into endogenous loci enables live imaging of proteins during tube formation. Tagged caveolin-1 or VE-cadherin can reveal dynamic localization in endothelial tubes. Knock-in of reporter cassettes can also monitor transcriptional activation of pro-angiogenic genes.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of candidate genes (e.g., THBS4, CCN2) can test whether increased expression enhances endothelial tube morphogenesis [5,8]. Overexpression of thrombospondin-4 with VEGF-C promotes lymphangiogenesis in bladder cancer models. These gain-of-function models complement knockout studies to establish causality [5,8].
How EDITGENE Supports positive regulation of endothelial tube morphogenesis Research
Researchers studying positive regulation of endothelial tube morphogenesis-related genes often need to determine whether a candidate gene is causally involved in enhancing or impairing tube formation. EDITGENE provides CRISPR-based cell model generation and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of endothelial tube morphogenesis research.
Frequently Asked Questions About positive regulation of endothelial tube morphogenesis
What is GO:1905956 positive regulation of endothelial tube morphogenesis?
GO:1905956 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis, the formation of endothelial tubes in blood and lymphatic vessels.
What genes are involved in positive regulation of endothelial tube morphogenesis?
Key genes include VEGFR2, CAV1, CCN2, ITGAV/ITGB5, DUSP6, ANGPT2, THBS4, VEGFC, and RNF213, among others [2,3,5,7,8,6].
How is endothelial tube morphogenesis positively regulated?
It is positively regulated by pro-angiogenic growth factors (e.g., VEGF-A, VEGF-C), integrin signaling, extracellular matrix cues, and intercellular communication via extracellular vesicles [4,5,8,1].
What diseases are linked to positive regulation of endothelial tube morphogenesis?
Cancer angiogenesis, Crohn's disease lymphangiogenesis, moyamoya disease, and endocrine-related vascular disorders have been linked to this process [3,1,6,2].
How can I study positive regulation of endothelial tube morphogenesis in the lab?
Common methods include tube formation assays, CRISPR knockout or overexpression, RNA-seq, phospho-ERK Western blotting, and live-cell imaging [3,5,6,8].
What is the role of caveolin-1 in endothelial tube morphogenesis?
Caveolin-1 is critical for endothelial tube formation and mural cell recruitment during tumor blood vessel maturation.
How does CCN2 regulate lymphangiogenesis?
CCN2 promotes lymphangiogenesis through integrin αvβ5-ERK signaling, which is regulated by DUSP6.
Does thrombospondin-4 affect lymphangiogenesis?
Yes, thrombospondin-4 drives lymphangiogenesis through cooperation with VEGF-C in human bladder cancer.
Can extracellular vesicles regulate lymphatic tube morphogenesis?
Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation, indicating positive regulation of lymphatic tube morphogenesis.
What CRISPR models are available for studying this process?
CRISPR knockout, point mutation, knock-in, overexpression, and library screening models can be generated in endothelial cells to test causal roles in tube morphogenesis [3,5,8].
Conclusion
Positive regulation of endothelial tube morphogenesis (GO:1905956) is a critical biological process that governs the formation of blood and lymphatic vessels. Its molecular players, including VEGFR2, caveolin-1, CCN2, and thrombospondin-4, are implicated in cancer, inflammatory bowel disease, and cerebrovascular disorders [2,3,5,8,1,6]. Understanding these positive regulators offers opportunities for therapeutic intervention in angiogenesis-dependent diseases. CRISPR-based cell models and screening platforms provide powerful tools to dissect the causal roles of candidate genes in endothelial tube morphogenesis. EDITGENE supports researchers with knockout, point mutation, knock-in, overexpression, and library screening services to accelerate discovery in this field.
References
- 1. Shu W et al.. 2024. Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation of Crohn's disease.. Clin Transl Med 14(12):e70086 PMID: 39623906
- 2. Fujii M et al.. 2012. Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma.. J Steroid Biochem Mol Biol 129(3-5):145-52 PMID: 22212769
- 3. Dewever J et al.. 2007. Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment.. Am J Pathol 171(5):1619-28 PMID: 17916598
- 4. Patan S. 2000. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling.. J Neurooncol 50(1-2):1-15 PMID: 11245270
- 5. Hashiguchi S et al.. 2022. CCN2-induced lymphangiogenesis is mediated by the integrin αvβ5-ERK pathway and regulated by DUSP6.. Sci Rep 12(1):926 PMID: 35042954
- 6. Zhao J et al.. 2022. LncRNA-mRNA Co-expression Profiles Relative to Vascular Remodeling in Moyamoya Patients Without RNF213 Mutation.. World Neurosurg 158:e880-e888 PMID: 34848385
- 7. Kang ML et al.. 2017. Angiopoietin-2 Enhances Osteogenic Differentiation of Bone Marrow Stem Cells.. J Cell Biochem 118(9):2896-2908 PMID: 28214341
- 8. Hwang TI et al.. 2026. Thrombospondin-4 drives lymphangiogenesis through cooperation with VEGF-C in human bladder cancer.. Int J Med Sci 23(1):204-215 PMID: 41399375
